Aug 21, 01:08 PM

J&J Invests $2 Billion in North Carolina Drug Plant as Tariffs Loom

Johnson & Johnson said on Thursday it will spend $2 billion over the next decade to expand U.S. drug manufacturing, securing space at Fujifilm Diosynth Biotechnologies’ new 160,000-square-foot plant in Holly Springs, North Carolina. The 10-year agreement will give the healthcare group additional capacity for biologic medicines and is expected to create roughly 120 jobs once the site becomes operational. The commitment builds on J&J’s broader strategy to increase domestic production. In March the company pledged to lift U.S. investment by 25% to more than $55 billion, including a separate facility in Wilson, North Carolina, and said further plant expansions will be outlined in the coming months. J&J’s move comes as the Trump administration prepares phased tariffs on imported pharmaceuticals that could eventually rise to 250%. Other large drugmakers such as Eli Lilly and AstraZeneca have also announced multi-billion-dollar U.S. projects in recent months, underscoring industry efforts to reduce exposure to potential trade penalties and strengthen domestic supply chains.

#Fujifilm Diosynth Biotechnologies #Holly Springs #North Carolina #Wilson #Trump #Eli Lilly #AstraZeneca

Written with ChatGPT .

Sources

Additional media

Image #1 for story j-j-invests-2-billion-north-carolina-drug-plant-tariffs-loom-cf8c0087

Image #2 for story j-j-invests-2-billion-north-carolina-drug-plant-tariffs-loom-cf8c0087

J&J Invests $2 Billion in North Carolina Drug Plant as Tariffs Loom

Sources

Additional media

Similar Stories